Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences
NCT05967494 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-08-01
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with chronic fatigue syndrome who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.
The data collected from this study will help improve future outcomes for all chronic fatigue syndrome patients as well as those in under-represented demographic groups.
Conditions
- Chronic Fatigue Syndrome
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-31
- Primary Completion
- 2025-08-31
- Completion
- 2026-08-31
Countries
- United States
Study Locations
More Related Trials
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642 ·Status: RECRUITING
-
MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis
NCT04620096 ·Status: COMPLETED
-
Cystic Fibrosis and Cognitive Function
NCT03820349 ·Status: COMPLETED
-
Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
NCT05912400 ·Status: COMPLETED
-
A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects
NCT03093714 ·Status: COMPLETED ·Phase: PHASE1
-
Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis
NCT03921229 ·Status: COMPLETED ·Phase: NA
-
Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI
NCT04391322 ·Status: ACTIVE_NOT_RECRUITING
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT05561868 ·Status: ACTIVE_NOT_RECRUITING
-
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
NCT03138772 ·Status: COMPLETED
-
CF Wellness Program
NCT07071324 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease
NCT00659529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Magnetic Resonance Imaging and Neuro-Psychological Testing In Cystic Fibrosis
NCT04451213 ·Status: COMPLETED ·Phase: NA
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Tissue Collection From People With Cystic Fibrosis
NCT00015756 ·Status: COMPLETED
-
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis
NCT00757848 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT04992234 ·Status: COMPLETED
-
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
NCT04921332 ·Status: TERMINATED ·Phase: NA
-
T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease
NCT04397861 ·Status: COMPLETED
-
Clinical Effort Against Smoke Exposure in Cystic Fibrosis
NCT04777344 ·Status: COMPLETED ·Phase: NA
-
Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo
NCT00515229 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT05614336 ·Status: COMPLETED ·Phase: NA
-
The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis
NCT06012084 ·Status: COMPLETED ·Phase: NA
-
Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience
NCT01013896 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)
NCT01025713 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of Training Intensity on Physical Fitness and Body Composition in Cystic Fibrosis
NCT05140967 ·Status: COMPLETED ·Phase: NA